Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study

…, C Paltiel, F Chedid, SK Felimban… - Pediatric blood & …, 2004 - Wiley Online Library
Background We compared the rates of infection in external catheters (ECs) and totally
implantable devices (TIDs) and the effect of timing of insertion in children with acute lymphoblastic …

A pilot study of prophylactic ciprofloxacin during delayed intensification in children with acute lymphoblastic leukemia

…, FD Chedid, AAH Abbas, SK Felimban… - Pediatric blood & …, 2004 - Wiley Online Library
Background We hypothesized that prophylactic administration of an appropriate antibiotic
following each delayed intensification (DI) in children with acute lymphoblastic leukemia (ALL) …

Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource‐rich developing country

…, BAC Iqbal, TM Khattab, S Felimban… - Pediatric Blood & …, 2015 - Wiley Online Library
Background The outcome of children with acute lymphoblastic leukemia (ALL) in developing
countries is less favorable than in developed countries, primarily due to resource constraints…

[HTML][HTML] Early vs. late MRD response-and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia

…, A Alkassar, M Daghistani, S Felimban - … hematology & oncology, 2018 - Springer
Background Refinement of risk-based treatment stratification by minimal residual disease (MRD)
at different time points has improved outcomes of childhood acute lymphoblastic …

[HTML][HTML] High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia

…, K Abdalla, AA AlAzmi, M Aseeri, S Felimban - Leukemia research …, 2018 - Elsevier
Sixty-three children (1–14 years of age) newly diagnosed with T-cell acute lymphoblastic
leukemia were treated from January 2001 to December 2014. Patient outcomes were …

Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?

…, N Elimam, K Abdalla, TM Khattab, S Felimban… - …, 2015 - Taylor & Francis
Objectives We aimed to determine whether the addition of two extra intrathecal methotrexate
(ITM) doses during induction in acute lymphoblastic leukemia (ALL) patients eliminate the …

Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia

…, K Abdalla, AA AlAzmi, A Algamal, S Felimban - …, 2019 - Taylor & Francis
Objectives: Acute lymphoblastic leukemia (ALL) with CNS2 status predicts inferior outcome
and a high rate of CNS relapse, similar to overt CNS leukemia (CNS3). The purpose of this …

[PDF][PDF] Stage 4S neuroblastoma, a disseminated tumor with excellent outcome

…, TM Khattab, GA Al-Sulami, SK Felimban - Saudi medical …, 2006 - researchgate.net
Methods. We retrospectively reviewed the charts of 75 patients with neuroblastoma diagnosed
and treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia between …

Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens

W Jastaniah, N Elimam, K Abdalla, S Felimban… - …, 2016 - Taylor & Francis
Objectives: Treatment regimens tested in major clinical trials, conducted by cooperative
groups, are often adapted as standard of care by cancer centers with the hope to replicate the …

Mucormycosis in children with acute lymphoblastic leukemia: report of 5 cases.

T Khattab, A Atra, S Felimban, H Kamal… - Cancer …, 2009 - search.ebscohost.com
Mucormycoses are serious fungal infections of immunocompromised patients which may
take several clinical forms according to the site affected. The diagnosis depends on …